Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Core Faculty in Innovation & Entrepreneurship
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993


Henson, Jacqueline B., Julius M. Wilder, Matthew R. Kappus, Andrew S. Barbas, Cynthia A. Moylan, Donna Niedzwiecki, Andrew J. Muir, Carl L. Berg, and Yuval A. Patel. “Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C.” Transplantation 104, no. 6 (June 2020): e164–73.

Full Text

Sulkowski, Mark, Annie F. Luetkemeyer, David L. Wyles, Claudia Martorell, Andrew Muir, Ilan Weisberg, Stuart C. Gordon, Richard McLain, and Gregory Huhn. “Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence.” Alimentary Pharmacology & Therapeutics 51, no. 12 (June 2020): 1384–96.

Full Text

Koutlas, Nicholas, Brian C. Allen, James H. Helzberg, Donna Niedzwiecki, Alice Parish, Mustafa R. Bashir, and Andrew J. Muir. “VALIDATION OF MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY RISK PREDICTION SCORES TO PREDICT CLINICAL EVENTS IN PRIMARY SCLEROSING CHOLANGITIS.” In Gastroenterology, 158:S1372–73, 2020.


Kapila, Nikhil, and Andrew J. Muir. “A Big Step Forward in Hepatitis C Screening.” Clin Liver Dis (Hoboken) 15, no. 4 (April 2020): 149–52.

Full Text

Dore, Gregory J., Jordan J. Feld, Alex Thompson, Marianne Martinello, Andrew J. Muir, Kosh Agarwal, Beat Müllhaupt, et al. “Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial.” J Hepatol 72, no. 3 (March 2020): 431–40.

Full Text

Younossi, Zobair M., Maria Stepanova, Ira Jacobson, Andrew J. Muir, Stanislas Pol, Stefan Zeuzem, Ziad Younes, et al. “Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes.” Clin Infect Dis 70, no. 4 (February 3, 2020): 628–32.

Full Text

Ocal, Selin, and Andrew J. Muir. “Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.” Curr Hiv/Aids Rep 17, no. 1 (February 2020): 18–25.

Full Text

Trauner, Michael, Yevgeniy Gindin, Zhaoshi Jiang, Chuhan Chung, G Mani Subramanian, Robert P. Myers, Aliya Gulamhusein, et al. “Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis.” Jhep Reports : Innovation in Hepatology 2, no. 1 (February 2020): 100060.

Full Text

Sanyal, Arun J., Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, Stephen Caldwell, Mitchell L. Shiffman, et al. “The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials.” Hepatology 70, no. 6 (December 2019): 1913–27.

Full Text

Muir, Andrew J. “Is Magnetic Resonance Cholangiopancreatography Worth a Thousand Words in Determining Prognoses of Patients With Primary Sclerosing Cholangitis?” Clin Gastroenterol Hepatol 17, no. 13 (December 2019): 2654–56.

Full Text